O
29.87
0.58 (1.98%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Mixed |
| Biotechnology (Global) | Mixed | Mixed | |
| Stock | Oruka Therapeutics, Inc. | Bullish | Bullish |
AIStockmoo Score
0.0
| Analyst Consensus | 3.0 |
| Insider Activity | NA |
| Price Volatility | -5.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 2.0 |
| Average | 0.00 |
|
Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| % Held by Insiders | 3.82% |
| % Held by Institutions | 86.62% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 63.00 (BTIG, 110.91%) | Buy |
| Median | 47.00 (57.35%) | |
| Low | 40.00 (HC Wainwright & Co., 33.91%) | Buy |
| Average | 50.33 (68.50%) | |
| Total | 6 Buy | |
| Avg. Price @ Call | 24.98 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| BTIG | 13 Nov 2025 | 63.00 (110.91%) | Buy | 26.38 |
| 29 Sep 2025 | 56.00 (87.48%) | Buy | 19.29 | |
| Jefferies | 13 Nov 2025 | 45.00 (50.65%) | Buy | 26.38 |
| Guggenheim | 27 Oct 2025 | 60.00 (100.87%) | Buy | 27.70 |
| HC Wainwright & Co. | 27 Oct 2025 | 40.00 (33.91%) | Buy | 27.70 |
| Barclays | 13 Oct 2025 | 48.00 (60.70%) | Buy | 25.51 |
| Clear Street | 17 Sep 2025 | 46.00 (54.00%) | Buy | 16.21 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 12 Nov 2025 | Announcement | Oruka Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update |
| 29 Oct 2025 | Announcement | Oruka Therapeutics to Present at Multiple November Investor Conferences |
| 17 Sep 2025 | Announcement | Oruka Therapeutics Announces $180 Million Private Placement |
| 17 Sep 2025 | Announcement | Oruka Therapeutics Announces Positive Interim Phase 1 Results for ORKA-001 |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 29 Aug 2024 | - | 28 Aug 2024 | 1.613 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2024 | 1.61 | 1 | 8.32 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |